Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults
Clinical trial NCT04588480 · COMPLETED
Trial details
- NCT number
- NCT04588480
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-11-25
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.